Navigation Links
Medicare HIT Incentive Update for the Oncology Practice - Free Educational Webinar
Date:7/18/2011

THE WOODLANDS, Texas, July 18, 2011 /PRNewswire/ -- One of the hot topics among healthcare providers continues to be how to achieve Meaningful Use requirements in the coming years. Community oncologists, practice administrators and clinical staff interested in learning more about Meaningful Use requirements and how these could affect community oncology practices are invited to attend a free webinar at 1 p.m. EDT (10 a.m. PDT) on Thursday, July 28, 2011. To register, visit http://www.myoncologyservices.com/. Registration is free, but space is limited.

"In addition to improving quality of care, physicians hope to earn up to $44,000 in incentives over the next five years as part of the approximately $20 billion allocated toward Electronic Health Record (EHR) adoption in the American Recovery and Reinvestment Act (ARRA, aka the stimulus package)," said Cindy Chavez, senior director of operations, Lynx and iKnowMed, products of McKesson Specialty Care Solutions | US Oncology. "As community-based oncologists, it is vitally important to understand how Meaningful Use can affect the community oncology practice and its staff. This interactive webinar will cover this crucial topic."

The informative web event will dive deep into Meaningful Use and the federal stimulus incentives and feature the following four expert presenters:

  • Cindy Chavez, senior director of operations, Lynx and iKnowMed
  • Peter Harrison, M.D., manager, Physician Products, iKnowMed
  • Andrew Johnston, product manager, iKnowMed
  • Geoff Werth, director, Federal Government Relations, McKesson Specialty Care Solutions | US Oncology

The presenters will draw from their experience with iKnowMed, an oncology-specific EHR that has achieved Complete Certification for Meaningful Use, and they will discuss what impact the Meaningful Use standards could have on community-based oncology practices. Other topics of discussion include an overview of Meaningful Use and recent proposed changes as well as important things for oncologists to consider before getting started on achieving Meaningful Use requirements. After the presentation, the speakers will hold an open discussion to address questions.

McKesson Specialty Care Solutions | US Oncology continues to invest in key areas including technology and quality programs to ensure that community-based oncologists and healthcare professionals are educated about pertinent topics. This event is being offered as a complimentary service and was designed to benefit physicians, practice administrators, and clinical staff.

About McKesson Specialty Care Solutions | US Oncology

McKesson Specialty Care Solutions | US Oncology, a division of McKesson Corporation, empowers the community patient care delivery system to advance the science, technology and quality of care. Through innovative clinical, research, business and operational solutions, facilitated by integrated technology systems, we improve the financial health of our customers and help them provide quality care for patients. For more information, visit www.mckesson.com/specialty and www.usoncology.com.

About McKesson

McKesson Corporation, currently ranked 15th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit www.mckesson.com.


'/>"/>
SOURCE US Oncology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Medicare Establishes Reimbursement Coverage for Vermillions OVA1(TM) Test
2. Study: Medicare Covers Only Half the Cost of Administering Chemotherapy to Seniors with Cancer
3. Medicare Administrator Establishes Reimbursement Coding Policy for Agendias Breast Cancer Recurrence Test MammaPrint(R)
4. Recently Approved Onglyza Is Covered by 44 Percent of Commercial Health Plans But Less Than One Percent of Medicare Plans for The Treatment of Type 2 Diabetes
5. Finance Committee Begins Markup - Lab Fee Converted to Medicare Cut
6. Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women
7. FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract
8. The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use
9. On-Line Medicare Advisor Saves Seniors Time, Hassle and Money
10. BioNeutral Group to Receive Economic Development Incentives
11. China Cord Blood Corporation Announces Cancellation of Nine Million Management Incentive Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, ... faculty of the University of North Carolina Kenan-Flagler Business School effective ... at UNC Kenan-Flagler, with a focus on the school’s international efforts, leading classes ...
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
Breaking Biology News(10 mins):